Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2

  • Susan MacLauchlan
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Jun Yu
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Marcus Parrish
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Tara A. Asoulin
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Michael Schleicher
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Marie M. Krady
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Jianmin Zeng
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Paul L. Huang
    Cardiovascular Research Center and Cardiology Division, Massachusetts General Hospital, Boston, MA 02129
  • William C. Sessa
    Interdepartmental Program in Vascular Biology and Therapeutics, and
  • Themis R. Kyriakides
    Interdepartmental Program in Vascular Biology and Therapeutics, and

説明

<jats:p>Injury- and ischemia-induced angiogenesis is critical for tissue repair and requires nitric oxide (NO) derived from endothelial nitric oxide synthase (eNOS). We present evidence that NO induces angiogenesis by modulating the level of the angiogenesis inhibitor thrombospondin 2 (TSP2). TSP2 levels were higher than WT in eNOS KO tissues in hind-limb ischemia and cutaneous wounds. In vitro studies confirmed that NO represses TSP2 promoter activity. Moreover, double-eNOS/TSP2 KO mice were generated and found to rescue the phenotype of eNOS KO mice. Studies in mice with knock-in constitutively active or inactive eNOS on the Akt-1 KO background showed that eNOS activity correlates with TSP2 levels. Our observations of NO-mediated regulation of angiogenesis via the suppression of TSP2 expression provide a description of improved eNOS KO phenotype by means other than restoring NO signaling.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ